LTRN Projected Dividend Yield
Lantern Pharma Inc ( NASDAQ : LTRN )Lantern Pharma Inc. is an artificial intelligence (AI) company. Co. is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. 21 YEAR PERFORMANCE RESULTS |
LTRN Dividend History Detail LTRN Dividend News LTRN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |